Searched for
COURT BIOCON BIOLOGICS
Biocon Biologics secures market entry for Yesafili in USBiocon Biologics has reached a settlement and licensing agreement with Regeneron, clearing the way for the US commercialization of Yesafili...- Stocks in news: TCS, Sun Pharma, Bharti Hexacom, Eternal, Greaves Cotton, Tata SteelTata Consultancy Services (TCS), India’s top software exporter, reported a 1.7% year-on-year decline in consolidated net profit to Rs 12,22...
- Biocon Biologics settles patent issue; paves way for launch of biosimilar product in CanadaBiocon Biologics has settled patent disputes with Bayer Inc and Regeneron Pharmaceuticals Inc, enabling the launch of Yesafili, an ophthalm...
- Stocks in news: Suven Pharma, MOIL, Adani stocks, ICICI Lombard, VedantaSuven Pharmaceuticals and Cohance Lifesciences signed a definitive agreement to merge their businesses, which will further strengthen the f...
- Quite comfortable about level of debt currently on our books: Shreehas Tambe, Biocon BiologicsSo from that point of view in the sense, of course, we expect it to be neutral or maybe slightly better but more or less neutral. On the ma...
- Govt grants sanction to prosecute joint drugs controller S Eswara Reddy in Biocon Biologics bribery caseEswara Reddy along with Animesh Kumar (Assistant Drugs Inspector), Biocon Biologics' Associate Vice President L Praveen Kumar, and Synergy ...
- Stocks in news: Zee Entertainment, Hero MotoCorp, Biocon, Greaves CottonOrient Cement has entered into a non-binding agreement with Adani Power Maharashtra for setting out the understanding for facilitating bona...
- Delhi HC grants bail to three in Biocon Biologics case"Though undoubtedly the offence alleged to have been committed (if proved) by the applicants is grave, the trial in the matter would take a...
- Biocon case: CBI files charge sheet against 5The agency in its charge sheet filed last week has annexed alleged incriminating WhatsApp texts exchanged between alleged conduit (a woman)...
- Allegations 'serious' & 'grave', says special court in Biocon Biologics caseThe special CBI court, in an 80-page order rejecting the bail pleas of all five accused in the case earlier this week, said: "The questions...
- Biocon Biologics bribery case: Bail pleas of five accused rejectedThe CBI last month arrested Central Drugs Standard Control Organisation (CDSCO) joint drug controller S Eswara Reddy and Biocon Biologics h...
- Biocon Biologics case: CBI seeks custodial interrogation of accusedThose arrested include a Joint Drug Controller (JDC), posted at CDSCO Headquarters, New Delhi, an executive of M/s Biocon Biologics Limited...
- Biocon Biologics bribery case: CBI yet to question Jt Drug Controller, other accusedA special court here had sent all the five accused, including a joint drug controller at Central Drugs Standard Control Organisation, to ju...
- Role of pharma firms in allegedly bribing CDSCO officials under CBI scannerCBI has arrested five people including S Eswara Reddy, joint drug controller at CDSCO, L Praveen Kumar, associate vice president and head o...
- Biocon, Mylan win US court ruling in favour of insulin GlargineUS District Court of New Jersey found the device patent claims (US Patent No. 9526844) asserted by Sanofi against Biocon and Mylan’s insuli...
- Stocks in the news: RCom, ICICI Bank, HDFC AMC, Jaiprakash Associates and Jet AirwaysHere are a few stocks which may buzz the most in Tuesday's trade.
- Roche vs Indian Pharma: The battle for a cheaper cancer drugThe companies in the thick of it are Roche, a $51 billion Swiss pharma major, and Biocon, the Bengaluru-based company led by India’s first ...
- CCI to investigate Swiss drugmaker Roche over breast cancer biosimilarCCI’s action is in response to a complaint filed by Mylan and Biocon, who have together developed biosimilar version of Roche’s blockbuster...
- Biocon, Mylan challenge ban on using Roche dataBangalore-based Biocon and US generic drugmaker Mylan have challenged Delhi High Court’s interim order which barred them from using Roche’s...
- Roche sues Biocon, Mylan, DCGI over breast cancer drugRoche has sued Mylan, Biocon for launching biosimilar version of the original breast cancer drug, Herceptin, and DCGI for allowing the laun...
Load More
